<--- Back to Details
First PageDocument Content
Clinical research / Pharmaceutical industry / Design of experiments / Medical ethics / Institutional review board / Clinical trial / Pharmacovigilance / Office for Human Research Protections / Adverse event / Human subject research / Serious adverse event / Adverse effect
Date: 2014-09-14 03:12:34
Clinical research
Pharmaceutical industry
Design of experiments
Medical ethics
Institutional review board
Clinical trial
Pharmacovigilance
Office for Human Research Protections
Adverse event
Human subject research
Serious adverse event
Adverse effect

Microsoft Word - Unanticipated_Problems

Add to Reading List

Source URL: www.firstclinical.com

Download Document from Source Website

File Size: 36,74 KB

Share Document on Facebook

Similar Documents

Web-Scale Pharmacovigilance: Listening to Signals from the Crowd Ryen W. White Ph.D.1*, Nicholas P. Tatonetti Ph.D.2, Nigam H. Shah M.B.B.S. Ph.D.3, Russ B. Altman M.D. Ph.D.4 and Eric Horvitz M.D. Ph.D.1 1 Microsoft Re

DocID: 1vpEW - View Document

Centre Anti Poison et de Pharmacovigilance du Maroc Société Marocaine de Toxicologie

DocID: 1v4Ie - View Document

Microsoft Word - Simple guide to Veterinary Pharmacovigilance in the EU

DocID: 1uY7F - View Document

PREPARATION D’UN DIPLOME DE TOXICOLOGIE - PHARMACOVIGILANCE   

DocID: 1uOXD - View Document

Liste des inscrits à la formation de toxicologie pharmacovigilance Année 2005 – 2006 Module « Pharmacovigilance » Nom Abouali Fatima Achour Sanaa

DocID: 1uKFW - View Document